VMware is a leading provider of multi-cloud services for all apps, enabling digital innovation with enterprise control. As a trusted foundation to accelerate innovation, VMware software gives businesses the flexibility and choice they need to build the future.
To ensure smooth, fast, and effective Epic EMR integrations, we developed the Imprivata OneSign® Connector for Epic. This tool leverages Epic's authentication API to add Imprivata’s capabilities seamlessly to Epic systems. For clinicians, this means faster and easier application log-on and log-off, and more efficient processing and signing of documentation, orders, and prescriptions. This programmatic integration also simplifies Epic deployments and maintenance.
Imprivata for Community Connect
MEDITECH empowers healthcare organizations everywhere to expand their vision of what’s possible with the world’s most intuitive and interoperable EHR. We’re laying the foundation for the next digital era by enabling care across delivery settings, designing cloud-based systems to drive better outcomes, and providing mobile, personalized solutions to improve efficiency for an overburdened workforce.
Elitemicro is a managed services provider and solution provider. We design, implement, manage and support our clients IT Infrastructure to enable them to focus on excelling in their endeavours along with providing solutions that harness technology and drive efficiencies.
We help our customers get the best from their IT investment by working with them throughout the IT lifecycle, from strategy and design to procurement, implementation and support.
HIStalkalooza 2014, sponsored by Imprivata, will be held Monday, February 24, 2014 from 7 p.m. until 11 p.m. at the House of Blues Orlando (Downtown Disney) during the HIMSS Annual Conference & Expo.
Lexington, Mass.—February 3, 2014—Imprivata, Inc. today announced that it has confidentially submitted a draft registration statement with the Securities and Exchange Commission (SEC) to conduct an initial public offering of its common stock. The offering is expected to commence after the SEC completes the review process of its draft registration statement.